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http://dxBackground: Several efforts are under way to conduct quality-improvement initiatives in pediatric cardiology
and cardiac surgery. Our goal was to develop an objective prioritization scheme for such initiatives based on
encounter frequency and relative contribution of quality measures of morbidity (and associated variances), par-
ticularly in the setting of low mortality.
Methods:We identified patients in the Pediatric Health Information System in Risk Adjustment for Congenital
Heart Surgery 1 category 1 to 6 for 32 pediatric cardiac surgical procedures conducted between 2003 and 2011
(n ¼ 67,550). These were examined for their overall contribution to mortality, intensive care unit and hospital
lengths of stay (coefficient of variation and excess days), adverse events, and readmission rates. A ranking
scheme was created on the basis of the outcome measures. Then we ordered the procedures across metrics to
develop a prioritization scheme.
Results: Observed mortality rates were consistent with published rates. A few procedures accounted for sig-
nificant variation in hospital and intensive care length of stay across the hospitals. Likewise, a few procedures
accounted for most excess days of stay and readmission rates. Up to 60% of the hospital stay was accounted
for by intensive care unit stay. Although there was a linear relationship between adverse event rates and Risk
Adjustment for Congenital Heart Surgery 1 categories, a few procedures once again accounted for dispropor-
tionate event rates within and across their respective Risk Adjustment for Congenital Heart Surgery 1 cate-
gories.
Conclusions: A small number of procedures account for a substantial burden of morbidity, even among low
mortality risk groups. Consideration should be given to using such objective prioritization schemes to develop
targeted quality-improvement measures. (J Thorac Cardiovasc Surg 2013;145:631-40)Earn CME credits at
http://cme.ctsnetjournals.org
There is growing interest in measuring and improving the
quality of care in pediatric cardiac surgery. Historically,
the outcome measure of greatest interest has been mortality,
with risk stratification schemes and effects of perioperative
care measures being defined by their impact on mortality.
However, it is increasingly being recognized that mortality
by itself is an inadequate marker of quality, particularly
with improving mortality data.1-4 Further, the risk-
stratification systems that were originally developed on
the basis of mortality data may not allow understanding
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The Journal of Thoracic and Caindividual operations that significantly contribute to quality
of care, for example, length of stay (LOS) or complications.
Someprofessional bodies, such as theAmericanCollegeof
Surgeons National Quality Improvement Program, are mov-
ing toward procedure-specific measures of performance,5-9
basing the decision on various initiatives based on relative
contribution of those specific procedures to observed
outcome measures. Others, such as the American College
of Cardiology Adult Congenital and Pediatric Cardiology
working group, are using consensus or expert opinion to
guide the selection of a quality improvement (QI) initiative.
From the perspective of QI, it makes sense to consider the
extent to which different operations contribute to overall
morbidity and mortality. Such an approach should account
for how frequently the operation is performed and its under-
lying complication rate. Alternatively, procedures could be
prioritized according to the excess cost or LOS attributable
to procedure-associated complications. Further, evidence of
significant variation in outcome measures and related prac-
tice patterns could highlight an opportunity for QI efforts
that optimize best practices for the affected population
and, thereby, reduce such variances. In this context, our
goal was to develop an objective approach for creating a pri-
oritization scheme for targeting QI efforts at commonly per-
formed pediatric cardiac surgical procedures. Specifically,
we describe the relative contribution of different pediatric
cardiac surgical procedures to length of intensive care unitrdiovascular Surgery c Volume 145, Number 3 631
Abbreviations and Acronyms
ASD ¼ atrial septal defect
ECMO ¼ extracorporeal membrane oxygenation
HLHS ¼ hypoplastic left heart syndrome
ICU ¼ intensive care unit
LOS ¼ length of stay
PA ¼ pulmonary artery
PHIS ¼ Pediatric Health Information System
QI ¼ quality improvement
RACHS-1 ¼ Risk Adjustment for Congenital Heart
Surgery 1
TAPVC ¼ total anomalous pulmonary venous
connection
VSD ¼ ventricular septal defect
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D(ICU) and hospital LOS, the associated variances, adverse
events, and readmission rates while accounting for their po-
tential contribution to mortality.MATERIALS AND METHODS
Study Cohort
We used data from the Pediatric Health Information System (PHIS) da-
tabase (Children’s Hospital Association, Overland Park, Kan) from 2003 to
2011. Hospital-level exclusions included elimination of data from any hos-
pitals with less than 3 years of data (n¼ 3 hospitals) and excluding from the
analysis to those centers that had a greater than 30% change in their annual
cardiac surgery volume during the period of study (n ¼ 5 hospitals). The
purpose of this latter exclusion was to limit data to those centers that
were not in a state of flux (ie, focus on stable systems). Therefore, deiden-
tified pediatric cardiac surgical cases reported by 35 participating hospitals
were chosen for analysis. The identified cohort was then categorized into
54 procedures on the basis of the Risk Adjustment for Congenital Heart
Surgery 1 (RACHS-1) classification system.10,11 Further, we wanted
to focus on ‘‘common’’ procedures. Consequently, procedures with
a frequency of less than 300 cases (ie, 1 case annually at any particular
institution) were not included in the analysis. Because RACHS-1 does
not have any exclusion criteria based on age for many procedures, to avoid
computing outcomes from heterogeneous age populations, we imple-
mented a patient-level exclusion based on age. Outliers that were outside
2 standard deviations from the 50% trimmed mean (n ¼ 38,815 subjects
excluded) within each procedure. Further, if thereweremultiple procedures
during a single admission, we chose the procedure with the highest
RACHS-1 score as the primary procedure. On the basis of the preceding,
from the original 54 procedure codes, 32 procedures were identified for fur-
ther data retrieval and analysis according to their overall contribution to the
total case volume within their respective risk category (Figure 1). In this
report, ventricular septal defect (VSD) repair associated with an atrial sep-
tal defect (ASD) repair and the isolated VSD groups were combined into 1
category/procedure. We elected not to study the neonatal patent ductus ar-
teriosus ligation procedure group (category 1 procedure) because many pa-
tients undergoing this procedure potentially have other comorbidities that
could account for their LOS or mortality beyond the surgery. Further, on
the basis of the inclusion/exclusion criteria we used, category 5 procedures
(mainly related to truncus arteriosus repair associated with interruption of
aortic arch) were excluded because there were too few cases. Last, we lim-
ited the neonatal coarctation repair cohort to those done without the use of
cardiopulmonary bypass (ie, eliminated 23% of neonatal coarctation repair
cases) to maintain a more homogenous population. We were particularly632 The Journal of Thoracic and Cardiovascular Surginterested in focusing on commonly performed procedures that are ex-
pected to have relatively low mortality rates (eg, RACHS-1 category 1-4)
but wanted to compare them with higher mortality procedures, such as
the Norwood procedure. There are already many ongoing QI research pro-
jects, such as the Pediatric Heart Network–funded Single Ventricle Recon-
struction study or the Joint Commission for Congenital Heart Disease
study, which are focused on improving outcomes after the Norwood proce-
dure. Therefore, we wanted to identify other areas with a potentially high
impact on the population with congenital heart disease (because of a high
frequency of encounter across many institutions).
Outcomes
Outcome variables assessed in this study included mortality during the
hospital admission, LOS in the hospital or ICU (and associated coefficient
of variation), adverse event rates based on modifications of a prior coding
algorithm,12 and readmissions within 14 days after hospital discharge.
Analysis
Expected mortality was calculated as previously described.13 We exam-
ined mortality outcomes for each procedure comparing with previously re-
ported data for RACHS-1 criteria using Flora’s z test.14 We evaluated
procedures according to overall hospital LOS, ICU LOS, and readmission
rates within 14 days after discharge.We calculatedmedianswith interquartile
ranges (25th-75th percentile) for each variable, where applicable. Although
we reasoned that ICU LOSwould directly be proportional to associated post-
operative morbidity that would complicate postoperative care, as shown by
others,15 we also looked at adverse event rates using modification of a previ-
ously validated algorithm. We included the use of extracorporeal membrane
oxygenation (ECMO) during that hospital admission as an additional event
category because it is an important and critical component for pediatric pa-
tients with cardiac disease.We also assessed the correlation between hospital
LOSand ICULOS todetermine the degree of ICUstay contribution tooverall
LOS using Spearman’s correlation. For binary outcomes, we compared rates
within and across RACHS-1 categories using generalized estimating equa-
tions to account for hospital clustering. For continuous outcomes, we made
comparisons usingmixedmodels to account for hospital clustering by includ-
ing ‘‘hospital’’ as a random effect. We then ordered the procedures according
to their contribution to the total case volumes, relative contribution tomortal-
ity, relative contribution to readmission within 14 days, and excess LOS. Ex-
cess LOS was defined as observed minus expected LOS if the observed was
greater than the expected, and zero otherwise. Expected LOS for each proce-
durewas calculated as the averageLOS in theHealthcareCost andUtilization
Project Kids’ Inpatient Database 2009 database. As a ‘‘tie-breaker’’ among
procedureswithout any associated excessLOS,weused the coefficient of var-
iation as a further discriminatory factor to tease out procedures with high ver-
sus low variation in LOS. Finally, we summed the ranks across the variables
for each procedure as an example prioritization scheme. All analyses were
performed with SAS version 9.2 (SAS Institute, Inc, Cary, NC).
RESULTS
Demographics and Volume
Pediatric cardiac procedure cases RACHS-1 categories 1
to 6 from 2003 to 2011 were identified in the PHIS database.
After application of hospital- and patient-level exclusion cri-
teria, 67,550 cases from 35 contributing hospitals were se-
lected for further analysis. From this cohort, we focused on
32 procedure groups because they were the primary proce-
dures within their respective RACHS-1 categories and al-
lowed for sufficient numbers of cases for procedure-level
analyses. The demographics of the cohort, including gender,
race, age, disposition, payor, RACHS-1 category, andLOS inery c March 2013
FIGURE 1. Average annual volume for each procedure. VSD, Ventricular septal defect; ASD, atrial septal defect; PA, pulmonary artery; TOF, tetralogy of
Fallot; AVC, atrioventricular canal; RV, right ventricle; PA, pulmonary artery; HLHS, hypoplastic left heart syndrome; TAPVR, total anomalous pulmonary
venous return; IAA, interruption of aortic arch; RVOT, right ventricular outflow tract; AS, aortic stenosis; PAPVR, partial anomalous venous return.
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Dhospital, are displayed in Table 1. For all hospitals, themajor-
ity of cases were in RACHS-1 categories 2 and 3. The distri-
bution of cases based onRACHS-1 categories was 11.2% for
category 1 (n ¼ 7552), 38.4% for category 2 (n ¼ 25,925),
41.3% for category 3 (n ¼ 27,896), 6.1% for category 4
(n ¼ 4115), and 3.1% (n ¼ 2062) for category 6. Figure 1
shows the distribution of the average annual volume for
each procedure across the hospitals. The largest portion of
cases in our datasetwereVSD repairs, followed by secundum
ASD and then systemic-to-pulmonary artery (PA) shunts.
Length of Stay
The overall hospital LOS and ICU LOS for the procedure
groups are shown in Table 2. The ICULOS data followed the
same pattern as seen for hospital LOS. The ICU LOS vari-
ability accounted for approximately 30% to 50% of overall
hospital LOSwithout any direct correlation to the RACHS-1
complexity.RACHS-1 classificationwas originally designed
for comparing mortality measures (and not, eg, LOS). Nev-
ertheless, increasing RACHS-1 risk category was associated
overall with a longer ICU and hospital LOS (P<.001).
All cases were performed with bypass with the exception
of coarctation repair at 30 days or less (0%) and in 11.4%
of coarctation repairs at 30 days or more. Other proceduresThe Journal of Thoracic and Cain which bypass was conducted in a proportion of the sub-
jects were systemic-to-PA shunts (54.6%), Glenn shunts
(88.8%), and the Fontan procedure (88.8%).
However, there were significant differences in median
hospital and ICU LOS within RACHS-1 risk categories.
The overall difference between ICU and hospital LOS aver-
aged only 4.5 days for RACHS-1 category 1 to 3 cases, in-
creasing suddenly to 14 days with RACHS-1 categories 4
to 6. Systemic-to-PA shunt procedures (difference of 14
days) and coarctation/VSD repair groups (difference of 10
days) accounted for approximately all of the difference of
hospital versus ICU days in the lower RACHS-1 groups.
In contrast, the RACHS-1 categories 4 to 6 were tightly
grouped around 12 to 17 days difference. The total excess
days for each procedure (observed LOS – expected LOS)
are displayed in Table 2. A few procedures accounted for ap-
proximately all excess days among all encounters: Systemic-
to-PA shunt, mitral valvuloplasty, and repairs of coarctation
and VSD had the greatest number of excess days, each con-
tributing more than 2000 excess days of stay. Last, even
among procedures with no associated excess days and over-
all short LOS (hospital or ICU), a few were associated with
significantly greater variation among various hospitals. For
example, resection of subaortic membrane was associatedrdiovascular Surgery c Volume 145, Number 3 633
TABLE 1. Demographics of cohort
N (%)
Gender
a. Male 37,641 (55.7)
b. Female 29,900 (44.3)
Race
a. Non-Hispanic white 35,805 (57.2)
b. Non-Hispanic black 6970 (11.1)
c. Hispanic 12,717 (20.3)
d. Asian 1892 (3)
e. Other 5184 (8.3)
Age
a.<2 y 48,855 (72.3)
b. 2-4 y 10,859 (16.1)
c. 5-9 y 4079 (6)
d. 10-14 y 2362 (3.5)
e. 15-18 y 1324 (2)
f.>18 y 71 (0.1)
Disposition
a. Home 60,381 (89.4)
b. Died 1893 (2.8)
c. Other 5276 (7.8)
Payor
a. Government 27,709 (41)
b. Private 26,257 (38.9)
c. Other 13,584 (20.1)
RACHS-1 category
1 7552 (11.2)
2 25,925 (38.4)
3 27,896 (41.3)
4 4115 (6.1)
6 2062 (3.1)
Length of stay (d)
a. 1-5 d 24,974 (37)
b. 6-10 d 17,598 (26.1)
c. 11-15 d 8218 (12.2)
d. 16þ d 16,760 (24.8)
RACHS-1, Risk Adjustment for Congenital Heart Surgery 1.
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Dwith less variation than repair of primum or secundumASD.
The differences in coefficients of variation were more no-
ticeable for overall hospital LOS than ICU LOS.
Adverse Events
Overall, increasing RACHS-1 classification was associ-
ated with higher adverse event rate, although there were
some notable exceptions, such as atrial switch procedure
(3.6% event rate) or sub-aortic stenosis resection (4.1%)
(Table 3). There were significant differences among differ-
ent procedures for types of events. For example, rates of re-
nal failure requiring dialysis were similar between various
procedures, including higher risk categories. In contrast,
risk of pneumonia or respiratory tract infection or need
for ECMO support was concentrated among a few proce-
dures. Overall event rate correlated with hospital and ICU
LOS. The event rate was not substantially different between
the RACHS-1 4 and 6 category procedures.634 The Journal of Thoracic and Cardiovascular SurgReadmission Rates
Data related to hospital readmission rates within 14 days
from discharge are shown in Table 3. As expected, there
were significant differences across the RACHS-1 categories
for readmission rates (P<.001), with readmission rates pro-
gressively increasing with increasing risk classification.
The highest readmission rate occurred for the Norwood
stage 1 repair of hypoplastic left heart syndrome (HLHS)
(category 4) and the Fontan procedure (category 3). How-
ever, readmission rates were also disparate within individ-
ual risk groups with significant differences between
category 2 and 3 procedures (both P< .001); these were
driven by the relatively high readmission rates for patients
after the Glenn shunt (category 2) and Fontan (category 3)
repair procedures, respectively.Mortality
We compared the observed versus expected mortality
groups on the basis of previously published RACHS-1 cri-
teria. The selected 32 procedures were found to have mor-
tality rates consistent with expected rates as previously
described10,11,14 (Table 3). The highest mortality rate was
for the Norwood procedures (category 6), repair of total
anomalous pulmonary venous return at 30 days or less (total
anomalous pulmonary venous return; category 4), and the
systemic-to-PA shunts (category 3).Prioritization Scheme
Prioritization of the procedures according to their contri-
bution to the total case volumes, relative contribution to
mortality, relative contribution to readmission within 14
days, any adverse event, and excess LOS (with secondary
discrimination based on coefficient of variation) is shown
in Table 4. Although it might be desirable to order proce-
dures according to only 1 of these metrics (eg, relative con-
tribution to mortality), we have ordered the procedures on
the basis of a balance of the metrics using ranks. Thus,
the lower the sum of the rank for a procedure, the higher
the priority for that procedure. With this approach, the top
3 ranked procedures (highest priority) are the systemic-to-
PA shunts, Fontan, and Norwood stage 1 repair for HLHS.DISCUSSION
Our original goal was to focus on procedures that are
commonly performed by many institutions and typically
associated with low mortality; we included the Norwood
procedure mainly for comparison/curiosity because there
are a number of QI initiatives already directed at the
latter. We were interested secondarily to see whether there
were significant variations in care, anticipating more
perturbations in any system that carries out these proce-
dures with high frequency. We found that a small number
of procedures (eg, systemic-to-PA shunts) account forery c March 2013
TABLE 2. Volume of procedures and length of stay
RACHS Procedure N
Age in days
median (IQR) % Bypass
Overall ICU
Median
LOS (IQR)
Total excess
days CV
Median
LOS (IQR) CV
1 ASD secundum repair 4109 1350 (895-1785) 100.0 3 (3-4) 0 256.7 1 (1-2) 477.7
1 Coarctation repair,>30 d 3019 132 (62-430) 11.4 5 (3-7) 0 173.8 2 (1-4) 213.5
1 Repair of PAPVR 424 1559 (1068-2234) 100.0 3 (3-4) 0 175.5 1 (1-2) 284.3
2 Aortic valvuloplasty,>30 d 1773 1858 (1078-2789) 100.0 4 (3-5) 0 180.9 1 (1-2) 314.8
2 ASD primum repair 1037 389 (165-829) 100.0 4 (3-7) 0 247.4 2 (1-3) 239.8
2 Coarctation repair, 30 d 2937 2 (1-7) 0.0 12 (7-20) 0 132.8 4 (2-7) 173.9
2 Glenn shunt 3163 168 (144-205) 88.8 7 (5-10) 0 121.0 2 (0-4) 189.8
2 Pulmonary valve replacement 1889 5123 (4093-6022) 100.0 4 (3-5) 0 96.4 2 (1-3) 153.5
2 Repair of TAPVR,>30 d 743 71 (49-112) 100.0 10 (6-15) 1718 205.1 4 (2-8) 176.4
2 RVOT procedure 1069 309 (148-769) 100.0 5 (4-8) 0 182.8 2 (1-4) 271.0
2 Sub-AS resection 728 1438 (1014-2089) 100.0 4 (3-5) 0 65.0 1 (1-2) 114.5
2 Total repair of TOF 3557 139 (107-176) 100.0 6 (5-9) 0 103.3 3 (2-5) 136.7
2 VSD closure and pulmonary
valvotomy
989 189 (117-272) 100.0 5 (4-8) 0 106.4 2 (1-4) 141.2
2 VSD repair 8040 138 (89-207) 100.0 5.5 (4-9) 0 138.6 2 (1-4) 182.6
3 Aortic valve replacement 1047 5435 (4817-6186) 100.0 6 (5-8) 1021 112.7 2 (1-4) 189.8
3 Arterial switch operation 2505 0 (0-1) 100.0 15 (12-21) 0 85.2 7 (3-11) 135.7
3 Atrial switch operation 741 1149 (631-1702) 100.0 4 (3-6) 0 116.8 1 (1-3) 176.7
3 Fontan procedure 3969 1099 (936-1262) 93.4 9 (7-13) 1401 93.4 3 (1-5) 156.5
3 Mitral valve replacement 786 3350 (1661-4665) 100.0 9 (6-15) 1889 96.8 3 (1-6) 151.3
3 Mitral valvuloplasty 2170 738 (238-1582) 100.0 5 (4-10) 3047 152.8 2 (1-4) 223.9
3 Repair of coarctation and
VSD
836 3 (1-8) 100.0 18 (13-31) 2900 114.1 8 (1-14) 124.1
3 Repair of TOF with RV-to-PA
conduit
627 167 (115-224) 100.0 8 (5-14) 0 127.3 3 (0-7) 204.7
3 Repair of transitional or
complete AVC
4124 143 (114-180) 100.0 7 (5-11) 0 165.5 3 (2-6) 189.1
3 Ross procedure 703 3683 (2176-4918) 100.0 5 (4-7) 0 81.4 2 (1-4) 101.3
3 RV-to-PA conduit 2832 643.5 (215-2095) 100.0 6 (4-14) 0 144.2 2 (1-6) 208.3
3 Systemic-to-PA shunt 5755 1 (0-2) 54.6 20 (13-34) 7391 120.7 6 (2-13) 203.5
3 Tricuspid valvuloplasty 1801 179 (108-397) 100.0 6 (4-12) 2023 175.5 3 (1-6) 214.2
4 Arterial switch operation with
VSD repair
1212 1 (0-1) 100.0 19 (14-25) 0 86.4 7 (0-12) 132.3
4 Repair of hypoplastic aortic
arch/IAA
883 2 (1-4) 100.0 24 (15-38) 2101 102.7 8.5 (2-15) 140.7
4 Repair of TAPVR, 30 d 1251 1 (0-1) 100.0 18 (12-30) 0 109.3 7 (0.5-14) 162.9
4 Repair of truncus arteriosus 769 1 (0-8) 100.0 22 (14-34) 590 90.5 8 (5-16) 129.8
6 Norwood: stage 1 repair of
HLHS
1364 0 (0-1) 100.0 27 (18-41) 1334 70.2 12 (0-21) 117.3
6 Norwood: stage 1 repair of
non-HLHS
698 1 (1-2) 100.0 28 (20-43) 2126 77.6 11 (0-19) 135.2
The 32 procedures chosen for the period of study are indicated with their respective RACHS-1 category designation, bypass rate, the cases or total number (N), and percent of the
category (in parenthesis), followed by the age of the patient cohorts in days (median, with IQR). RACHS,Risk Adjustment for Congenital Heart Surgery; IQR, interquartile range;
LOS, length of stay; CV, cardiovascular; ICU, intensive care unit; ASD, atrial septal defect; PAPVR, partial anomalous venous return; TAPVR, total anomalous pulmonary venous
return; RVOT, right ventricular outflow tract; AS, aortic stenosis (produced by an obstruction in the left ventricle at the aortic valve); TOF, tetralogy of Fallot; VSD, ventricular
septal defect; RV, right ventricle; PA, pulmonary artery; AVC, atrioventricular canal; IAA, interruption of aortic arch; HLHS, hypoplastic left heart syndrome.
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among these commonly performed procedures. We also ob-
served, perhaps not surprisingly, that some of the relatively
simple procedures had substantially higher variation in LOS
(both hospital and ICU) compared with the more complex
procedures. Likewise, a few procedures accounted for the
highest burden of adverse event and readmission rates.The Journal of Thoracic and CaWe also reanalyzed our data while censoring for mortality,
and the results were not changed (data not shown). These
findings suggest that QI measures directed at a few proce-
dures may have significant impact for overall outcomes.
One of the important findings of our study was the quan-
tification of significant variation in hospital and ICU LOS,
particularly for relatively ‘‘low-risk’’ procedures and therdiovascular Surgery c Volume 145, Number 3 635
TABLE 3. Event rates
RACHS
level Procedure
Adverse events
Readmission Mortality
Acute renal
failure
requiring
dialysis
Pneumonia and
other lower
respiratory
infections
Wound
infection or
cellulitis
Sepsis
requiring
pressors
Cardiac
arrest or
dysrhythmia
requiring CPR ECMO
Any
event
1 ASD secundum repair 0.1 3.4 0.5 0.5 0.1 0.2 4.3 2.2 0.1
1 Coarctation repair,
>30 d
0.0 6.0 0.4 1.1 0.3 0.2 7.4 1.7 0.1
1 Repair of PAPVR 0.0 2.8 0.0 0.0 0.2 0.0 3.1 0.9 0.0
2 Aortic valvuloplasty,
>30 d
0.1 3.7 0.3 0.6 0.3 0.4 4.8 2.1 0.3
2 ASD primum repair 0.1 6.1 1.1 1.9 0.3 0.3 8.0 2.6 0.7
2 Coarctation repair,
30 d
0.1 7.0 3.6 4.2 0.7 0.5 14.3 4.6 2.8
2 Glenn shunt 0.0 12.3 3.6 1.8 0.7 0.6 16.5 6.1 1.8
2 Pulmonary valve
replacement
0.1 6.4 0.3 0.3 0.1 0.2 7.0 2.5 0.2
2 Repair of TAPVR,
>30 d
0.1 12.0 0.8 4.4 0.9 2.3 16.2 3.9 2.2
2 RVOT procedure 0.4 9.9 1.0 2.5 0.8 0.7 13.3 2.7 2.2
2 Sub-AS resection 0.1 2.3 0.1 1.4 0.0 0.3 4.1 0.8 0.1
2 Total repair of TOF 0.0 9.5 1.1 2.1 0.5 0.6 12.3 2.9 0.3
2 VSD closure and
pulmonary
valvotomy
0.1 7.2 1.1 2.3 0.7 1.8 11.8 2.6 1.8
2 VSD repair 0.0 9.0 0.9 1.7 0.3 0.5 11.6 2.9 0.4
3 Aortic valve
replacement
0.5 6.8 1.4 2.5 0.6 0.8 11.2 5.7 1.0
3 Arterial switch
operation
0.1 6.3 6.2 4.0 0.4 4.6 18.8 2.7 2.6
3 Atrial switch
operation
0.0 3.2 0.3 0.1 0.0 0.3 3.6 2.6 0.1
3 Fontan procedure 0.5 14.4 2.8 2.5 0.4 1.0 18.3 9.0 1.8
3 Mitral valve
replacement
0.8 10.2 2.4 5.5 1.1 1.7 17.2 5.2 2.8
3 Mitral valvuloplasty 0.1 10.1 1.3 2.0 1.3 1.2 13.8 3.8 1.5
3 Repair of coarctation
and VSD
0.1 10.3 5.5 6.3 1.3 2.4 20.8 4.4 3.0
3 Repair of TOF with
RV-to-PA conduit
1.6 14.0 1.4 5.4 1.4 3.5 20.9 4.1 0.8
3 Repair of transitional
or complete AVC
0.1 11.0 1.7 2.4 0.7 0.9 14.5 4.9 0.9
3 Ross procedure 0.1 7.4 0.1 1.3 0.6 0.9 10.1 3.1 0.6
3 RV-to-PA conduit 0.2 10.6 2.9 3.0 1.2 2.4 16.7 4.5 2.9
3 Systemic-to-PA shunt 0.2 6.5 8.3 5.5 2.4 6.3 24.3 5.5 9.3
3 Tricuspid
valvuloplasty
0.0 9.6 1.3 2.6 0.6 0.8 14.4 4.9 1.6
4 Arterial switch
operation with VSD
repair
0.8 11.2 8.2 5.0 1.1 6.0 30.6 2.9 4.9
4 Repair of hypo/IAA 0.9 9.7 7.5 8.6 0.7 4.5 31.0 5.8 7.0
4 Repair of TAPVR,
30 d
1.4 9.2 6.6 7.0 2.2 12.3 29.0 4.6 15.3
4 Repair of truncus
arteriosus
0.5 10.4 9.4 9.2 2.1 6.4 32.6 4.6 8.1
(Continued)
Congenital Heart Disease Eghtesady et al
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TABLE 3. Continued
RACHS
level Procedure
Adverse events
Readmission Mortality
Acute renal
failure
requiring
dialysis
Pneumonia and
other lower
respiratory
infections
Wound
infection or
cellulitis
Sepsis
requiring
pressors
Cardiac
arrest or
dysrhythmia
requiring CPR ECMO
Any
event
6 Norwood: stage 1
repair of HLHS
0.7 10.0 9.4 8.7 3.7 10.3 35.0 9.5 16.2
6 Norwood: stage 1
repair of non-HLHS
1.6 12.2 9.3 10.5 3.6 14.9 36.5 6.0 15.6
Adverse events for the different procedures and readmission and mortality rates are shown. RACHS, Risk Adjustment for Congenital Heart Surgery; CPR, cardiopulmonary re-
suscitation; ECMO, extracorporeal membrane oxygenation; ASD, atrial septal defect; PAPVR, partial anomalous venous return; TAPVR, total anomalous pulmonary venous re-
turn; RVOT, right ventricular outflow tract; AS, aortic stenosis (produced by an obstruction in the left ventricle at the aortic valve); TOF, tetralogy of Fallot; VSD, ventricular septal
defect; RV, right ventricle; PA, pulmonary artery; AVC, atrioventricular canal; IAA, interruption of aortic arch; HLHS, hypoplastic left heart syndrome.
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good targets for QI efforts and perhaps a subject of collab-
orative work groups as has been done in the adult cardiac
care setting (eg, New England Collaborative). Potential
standardization of care and learning from the best may
lead to decreased variance and potentially improved out-
comes. Also, further analysis of these data will allow iden-
tification of mitigating factors that may be modifiable and
result in lower variance. Our data also show that the ICU
LOS on average accounted for approximately 60% of all
variation in hospital LOS. ICU LOS likely serves as a surro-
gate of complications that result in longer ICU stay, as sug-
gested by others.15 Of note, in our study the patient age was
adjusted to take out outliers that would have a significant
impact on these findings (eg, ASD repair in a neonate is
likely driven by different circumstances vs that in a 3-
year-old). Therefore, the observed variances likely reflect
system-dependent factors that can be modified.
We found that a few procedures accounted for the substan-
tial burden of adverse event and readmissions, with once again
the Norwood stage 1 repair of HLHS, Fontan procedures, and
Glenn shunt accounting for the greatest contributions. QImea-
sures are already ongoing to improve outcomes after the Nor-
wood procedure; additional QI measures that focus on the
Fontan and Glenn procedures could further improve the con-
tinuum of care for these patients with single-ventricle physiol-
ogy.Are the increased readmissionsmainly related to recurrent
pleural effusions that occur secondary to premature reduction
or discontinuation of diuretic regimen?Moreover, patients un-
dergoing systemic-to-PA shunting contributed significantly to
readmissions, but with their already high baseline LOS, these
patients have one of the longest hospital stays (ie, by combin-
ing the initial and readmit hospitalizations). Are these higher
readmission rates because the patients are discharged too
soon or is it reflective of inadequate anticoagulation regimens
leading to recurrent shunt thrombosis or other technical param-
eters in play that need to be addressed? Whether systemic-to-
PA shunt procedures are amenable to intervention or are an
inherent risk factor for the patient population who undergo
this procedure16 deserves further investigation.The Journal of Thoracic and CaOur mortality data were consistent overall with prior re-
ports using the RACHS-1 classification.10,11,14 Further, our
results are consistent with limited procedure-specificmortal-
ity data recently published.13,17,18 These data suggest that
overall outcomes for certain procedures have improved
since inception of the RACHS-1 classification system (eg,
for patients undergoing the Fontan or repair of complete
atrioventricular canal), but continues to be problematic for
a subset of babies, for example, those undergoing
systemic-to-PA shunting. Whether the latter reflects a non-
modifiable risk factor based on the unique high-risk patient
population versus modifiable elements for that procedure re-
mains to be seen.Althoughwe analyzed total anomalous pul-
monary venous return procedures as 2 separate groups based
on their median age, at 30 days or less and 30 days or more
(neonates) this may not be ideal. The neonates may be cases
who were missed at 30 days or less and may be presenting
later for urgent interventions. The group aged more than 30
days also may be patients with nonobstructed total anoma-
lous pulmonary venous connection (TAPVC) performed
electively, especially those with cardiac TAPVC and a few
with supracardiac TAPVC. The Society of Thoracic Sur-
geons–European Association for Cardio-Thoracic Surgery
Congenital Heart mortality categories,13 which represent
an alternative methodology for calculation and reporting of
mortality outcomes, could overcome the limitations of cod-
ing encountered by using the RACHS-1 categories.
Study Limitations
It is important to acknowledge the potential limitations of
this study. The first limitation is that our database is substan-
tially overrepresented by large teaching hospitals. Of the 35
hospitals that participated in our study, only 1was not a teach-
ing hospital. Academic hospitals may differ from community
hospitals with regard to their procedure mix and other out-
come measures. Both factors could affect the generalization
of our findings. Also, the usual limitation of an administrative
database (eg, lacking detailed clinical data, variations in cod-
ing accuracy, and limitations of International Classification
of Diseases, 9th and 10th Revision codes for diagnosis andrdiovascular Surgery c Volume 145, Number 3 637
TABLE 4. Prioritization scheme based on ranks
RACHS
level Procedure
Any event Readmission Mortality LOS
Sum rank Priority% Total Rank % Total Rank % Total Rank
% Excess
total Rank
Mod
rank*
1 ASD secundum repair 1.7 19 3.2 10 0.3 25 0.0 13 13 67 17
1 Coarctation repair,>30 d 2.2 18 1.9 16 0.2 28 0.0 13 18 80 23
1 Repair of PAPVR 0.1 33 0.1 33 0.0 33 0.0 13 17 116 30
2 Aortic valvuloplasty,>30 d 0.8 28 1.3 21 0.3 26 0.0 13 16 91 25
2 ASD primum repair 0.8 29 1.0 27 0.4 24 0.0 13 14 94 26
2 Coarctation repair, 30 d 4.1 10 4.8 6 4.4 5 0.0 13 23 44 9
2 Glenn shunt 5.1 5 6.9 5 3.0 12 0.0 13 24 46 10
2 Pulmonary valve replacement 1.3 23 1.7 18 0.2 30 0.0 13 29 100 27
2 Repair of TAPVR,>30 d 1.2 25 1.0 26 0.8 21 6.2 8 8 80 23
2 RVOT procedure 1.4 21 1.0 25 1.3 18 0.0 13 15 79 22
2 Sub-AS resection 0.3 31 0.2 32 0.1 32 0.0 13 33 128 33
2 Total repair of TOF 4.2 9 3.7 9 0.5 23 0.0 13 28 69 19
2 VSD closure and pulmonary
valvotomy
1.1 27 0.9 28 1.0 20 0.0 13 27 102 28
2 VSD repair 9.1 2 8.2 3 1.8 14 0.0 13 21 40 4
3 Aortic valve replacement 1.1 26 2.1 14 0.5 22 3.7 11 11 73 20
3 Arterial switch operation 4.6 8 2.4 13 3.5 8 0.0 13 31 60 14
3 Atrial switch operation 0.3 32 0.7 31 0.1 31 0.0 13 25 119 31
3 Fontan procedure 7.1 3 12.8 1 3.7 7 5.1 9 9 20 2
3 Mitral valve replacement 1.3 22 1.5 20 1.2 19 6.9 7 7 68 18
3 Mitral valvuloplasty 2.9 13 3.0 12 1.7 15 11.1 2 2 42 7
3 Repair of coarctation and
VSD
1.7 20 1.3 22 1.3 17 10.5 3 3 62 16
3 Repair of TOF with RV-to-PA
conduit
1.3 24 0.9 29 0.3 27 0.0 13 22 102 28
3 Repair of transitional or
complete AVC
5.8 4 7.2 4 2.1 13 0.0 13 19 40 4
3 RV-to-PA conduit 4.6 7 4.6 8 4.3 6 0.0 13 20 41 6
3 Systemic-to-PA shunt 13.6 1 11.3 2 28.4 1 26.8 1 1 5 1
3 Tricuspid valvuloplasty 2.5 15 3.1 11 1.5 16 7.3 6 6 48 12
4 Arterial switch operation with
VSD repair
3.6 11 1.2 24 3.1 11 0.0 13 30 76 21
4 Repair of hypo/IAA 2.7 14 1.8 17 3.3 10 7.6 5 5 46 10
4 Repair of TAPVR, 30 d 3.5 12 2.0 15 10.1 3 0.0 13 26 56 13
4 Repair of truncus arteriosus 2.4 17 1.2 23 3.3 9 2.1 12 12 61 15
6 Norwood: stage 1 repair of
HLHS
4.6 6 4.6 7 11.7 2 4.8 10 10 25 3
6 Norwood: stage 1 repair of
non-HLHS
2.5 16 1.5 19 5.8 4 7.7 4 4 43 8
Columns labeled ‘‘% Total’’ sum to 100% and refer to the percent of the event from the specified procedure. RACHS, Risk Adjustment for Congenital Heart Surgery; LOS, length
of stay; ASD, atrial septal defect; PAPVR, partial anomalous venous return; TAPVR, total anomalous pulmonary venous return; RVOT, right ventricular outflow tract; AS, aortic
stenosis (produced by an obstruction in the left ventricle at the aortic valve); TOF, tetralogy of Fallot; VSD, ventricular septal defect; RV, right ventricle; PA, pulmonary artery;
AVC, atrioventricular canal; IAA, interruption of aortic arch; HLHS, hypoplastic left heart syndrome. *Modified rank was created using the rank of the coefficient of variation to
break ties in the rank of the percent of excess days.
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linked Society of Thoracic Surgeons Congenital Heart
Surgery Database and the PHISDatabase22 to perform a sim-
ilar analysis as reported in this article could further strengthen
the proof of concept our study shows. Perhaps the greatest
limitation of our study (or any similar study) is that it does
not provide information on what is the most important com-
ponent of any QI initiative: the quality of the experience for
the patient or their family.638 The Journal of Thoracic and Cardiovascular SurgWhen we initiated this study, we intended to obtain com-
prehensive data related to adverse events, such as those
measures reported by others as in Agency for Healthcare
Research and Quality safety indicators or the Wisconsin-
modified Agency for Healthcare Research and Quality ad-
verse events. However, these measures have not been
adjusted or validated for pediatric cardiac surgery, limiting
their application at least in their current state. We used a de-
rivative of an algorithm applied to pediatric patientsery c March 2013
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were unable to capture neurologic events that would be an
important component of assessing morbidity. Our data set
did not allow for examination of unplanned reintervention
rates. Future studies, such as those using the linked Society
of Thoracic Surgeons-PHIS database, that provide insight
on these variables can further help with prioritization
schemes. Finally, our data do not explain the reason for
the significant variation in care for the various procedures.
Perhaps center- or institution-specific features have some
impact in this regard. These could be the subject of future
investigations.
Our results have the following implications for QI efforts
in pediatric cardiac surgery. First, the data might be used as
a guide to prioritize local QI efforts at individual institutions
based on their case mix.23 We have provided a number of
‘‘priority lists’’ based on various ranking algorithms; these
can be modified as desired and provide a concept of which
areas to focus on to implementQImeasures. For professional
organizations, our findingsmight be useful in targeting large-
scale QI efforts beyond subjective, consensus opinion; other
data sets can be used for validation of such schemes or to de-
velop more robust prioritization schemes in an objective
manner. Finally, our findings are relevant to current policy
discussions regarding healthcare reform and associated costs
as one may use similar approaches to identify high-leverage
procedures, in terms of their potential for not only improving
patient outcomes but also reducing excess cost.
Our study does not assess the extent to which QI could
reduce any parameter for each procedure. Therefore, indi-
vidual organizations and improvement teams would likely
want to consider other factors in setting their QI priorities.
In particular, it would be important to weight the potential
of each procedure for a QI initiative, even though we tried
to focus on the higher-volume procedures.CONCLUSIONS
Future work should aim to improve our current under-
standing of processes of care associated with observed out-
comes and objectively lead to QI initiatives that improve
care across many institutions that currently care for children
with congenital heart disease.References
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Dr James Jaggers (Aurora, Colo). As you describe, measure-
ment of quality and performance in the management of our pa-
tients with congenital heart disease is challenging because of the
vast variety of congenital defects, the variability of presentation,
and the severity of illness. It makes it difficult for even complex
analyses like this one to capture that. I do like your idea of a prior-
itization system, something that takes into account not only the
mortality figures but also those areas that we know are problems
(eg, reintervention, readmission). You use the PHIS database,rdiovascular Surgery c Volume 145, Number 3 639
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field. But it has important limitations as you described. It is retro-
spective and observational. It is fraught with coding errors, and it
captures charges but not cost. It does have a lot of power advan-
tages, so eventually efforts like this to improve our quality are go-
ing to take a combination of different databases, such as registries
and the administrative databases. With that comment aside, I have
a couple questions for you.
Why did you use the RACHS system in your prioritization
rather than the more newly combined stratification system, the Eu-
ropean Association for Cardio-Thoracic Surgery (EACTS)/Soci-
ety of Thoracic Surgeons (STS)? One of the reasons you did this
study seems to be because you did not like the consensus-based
classification. Why not use a data-derived classification system
like the EACTS-STS system?
Dr Eghtesady. Simplistically, because the RACHS is an easy al-
gorithm that allows pulling procedures out of administrative data-
bases based on International Classification of Diseases 9th Revision
codes. You basically have to access the STS/EACTS database. There
is no algorithm that you can apply to the administrative database to be
able to pull that data, but I think one could do exactly the same thing
with the STS database, which is ease of access to the PHIS database
and being able to pull the data using the RACHS algorithm.
Dr Jaggers. Just by way of clarification, when you talk about
LOS in your study, does that include the preoperative LOS or is
this strictly postoperative LOS?
Dr Eghtesady. No, it is from admission to discharge, so there
could be a period of preoperative stay included in that.
Dr Jaggers.That is an important distinction whenwe start com-
paring different databases and outcomes that are related to LOS. I
am always a little skeptical about complication rates in the PHIS
database. As you know, hospitals get reimbursed according to
these diagnosis-related groups and the rates of complications. Is
there any way within your study that you can reassure us that
the complication rates are not significantly different between insti-
tutions and different payors?
Dr Eghtesady. Yes and no. You are absolutely right, and I am
skeptical of them to some extent. With that said, just looking at640 The Journal of Thoracic and Cardiovascular SurgICU LOS, which others have shown to be a surrogate marker of
complications, the data (ie, the prioritization and all that) still
hold and correlated with the events rate that we saw, so even
though we may be undercapturing the events and this is a deriva-
tion of a derivation, there is a lot of reach there if you will. I
think the data you see are not necessarily inaccurate. I think
the data are underrepresenting; we are not seeing all the compli-
cations that should be there. Additional effort needs to go into
providing definitions. For example, neurologic events is missing,
and specifically the reason is until 2010 the database, PHIS data-
base, did not have a category to identify whether the child pre-
senting at admission had a neurologic problem at baseline or
not, so using the definitions that have been used in the past would
have given us an unmeaningful response. The database includes
select events and is not completely accurate, but my confidence
lies in the fact that it correlates nicely with ICU LOS,
which is a reasonable assumption to say it is a surrogate for
complications.
Dr Jaggers. As you have described, the PHIS database’s
advantage is that it contains more than 5 million inpatient en-
counters and with that comes charge data for which cost data
can be derived. We are going to be judged on value essentially
and quality and cost. What is your opinion as you look for-
ward? Do you think it is time for us to start including cost
within these prioritization screens? What do you think about
that?
Dr Eghtesady. Great question, and the short answer is yes. I
talked about it with Matt Hall, but the reality was for us to be
able to pull that off was going to be challenging because it
seemed like we had so much in there. You and Ross Ungerleider
were kind enough to provide reference to me, an article that you
guys had published a long time ago where you looked at costs at
Duke with 140 procedures and looked at variation and how
ASD repair was a reliable cost versus VSD, which was more
variable. That is an important thing to look at, and in the future
that would be one of the things that would definitely be worth
looking at.
Dr Jaggers. Thank you.ery c March 2013
